Trial ID: | L0878 |
Source ID: | IRCT2015030721358N1
|
Associated Drug: |
Omega-3 Fatty Acids
|
Title: |
Investigation of mechanism of supplementation effect with omega-3 on lipid profile and peroxidation , inflammatory markers, insulin resistance and liver function in patients with non-alcoholic fatty liver (NAFL) compared with control group.
|
Acronym: |
--
|
Status: |
Not Recruiting
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
(Nonalcoholic fatty liver disease (NAFLD. <br>(Nonalcoholic fatty liver disease (NAFLD;(Nonalcoholic fatty liver disease (NAFLD
|
Interventions: |
Intervention 1: intervention group: Omega-3 supplement with effective dosage of 900 mg/day, 3*300 mg capsules per day for 2 month. Intervention 2: control group: 3 capsules of placebo per day for 2 month.;Treatment - Drugs;Placebo;intervention group: Omeg
|
Outcome Measures: |
Lipid profile. Timepoint: before intervention and 2 months after intervention. Method of measurement: mg/dl with autoanalyzer.;Inflammatory markers. Timepoint: before intervention and 2 months after intervention. Method of measurement: ELISA.;Sugar profile. Timepoint: before intervention and 2 months after intervention. Method of measurement: mg/dl with autoanalyzer.;Insulin Resistance. Timepoint: before intervention and 2 months after intervention. Method of measurement: HOMA-IR.Liver enzymes. Timepoint: before intervention and 2 months after intervention. Method of measurement: Autoanalyzer.
|
Sponsor/Collaborators: |
Ahvaz Jundishapur University of Medical Sciences
|
Gender: |
All
|
Age: |
18 yearsno limit
|
Phases: |
Not applicable
|
Enrollment: |
40
|
Study Type: |
interventional
|
Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
Start Date: |
11/04/2015
|
Completion Date: |
--
|
Results First Posted: |
--
|
Last Update Posted: |
22 February 2018
|
Locations: |
Iran (Islamic Republic of)
|
URL: |
http://en.irct.ir/trial/18740
|